Ascribe Bioscience: Funding, Investors & Team (Sep 2026)
Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment. The company is currently developing a seed treatment product that acts by boosting crops’ natural defenses. Ascribe Bioscience was founded in 2017 and is headquartered in Ithaca, New York.
Ascribe Bioscience has raised $3.0M across 2 funding rounds on record, the most recent a Grant of $500k announced in Nov 2021.
That round is below the $3.3M median round size for Agriculture and Farming companies tracked on FundedIQ over the last two years.
Ascribe Bioscience Company Profile and Key Stats
Latest funding round on record: Nov 2021.
Ascribe Bioscience Funding Rounds
Ascribe Bioscience raised $2.5M in an undisclosed round announced in Sep 2021.
2 months later, a Grant of $500k was announced in Nov 2021.
Ascribe Bioscience Founders and Leadership Team
No contact details are on record for this team yet.
Ascribe Bioscience Funding Compared to Other Agriculture and Farming Startups
Ascribe Bioscience's latest round of $500k is below the median round in Agriculture and Farming. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ascribe Bioscience in Agriculture and Farming and Ithaca
Companies Similar to Ascribe Bioscience
RevaTerra is an energy company that develops bioenergy solutions using artificial intelligence to transform…
Ambrook provides tailored accounting software for family-owned farms, ranches, and agricultural businesses.…
Hippo Harvest develops an agriculture technology to help scale sustainable agriculture. It was founded in…
Pursell Agri-Tech develops and commercializes fertilizers to increase crop yields and improve human…
Novilla RNG is a biogas consulting and dairy renewable natural gas developer.
Gratwick is an entertainment company that operates a community-driven platform for live film and TV…
Maalexi is a next-generation B2B trade platform empowering verified Small and Medium Enterprises (SME) to…
Well Water Finders® is a groundwater intelligence company combining patented remote-sensing technology with…
Heartstone Farm is a farm that sells beef, chicken, and turkey meat products.
Arcadia Biosciences is an agricultural technology company focused on developing products that benefit the…
California Reserve Flower is an operator of cannabis cultivation company producing premium flowers and…
Leaf is a data network that connects apps and services to farm data from equipment, sensor, and software…
Ascribe Bioscience Funding FAQs
What does Ascribe Bioscience do?
Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment. The company is currently developing a seed treatment product that acts by boosting crops’ natural defenses. Ascribe Bioscience was founded in 2017 and is headquartered in Ithaca, New York.
How much funding has Ascribe Bioscience raised?
Ascribe Bioscience has raised $3.0M across 2 rounds on record. The most recent is a Grant of $500k announced in Nov 2021.
When did Ascribe Bioscience last raise funding?
Ascribe Bioscience's most recent funding round on record is a Grant of $500k, announced in Nov 2021.
Who is the CEO of Ascribe Bioscience?
Jay Farmer is listed as CEO at Ascribe Bioscience.
Where is Ascribe Bioscience headquartered?
Ascribe Bioscience is based in Ithaca, New York, United States.
How many employees does Ascribe Bioscience have?
Ascribe Bioscience is in the 1-10 employee band.
How does Ascribe Bioscience's funding compare to other Agriculture and Farming startups?
Ascribe Bioscience's latest round of $500k is below the $3.3M median round size for Agriculture and Farming companies on FundedIQ across 1,320 tracked companies over the last two years.
About FundedIQ's Ascribe Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ascribe Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.